SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunoGen
IMGN 31.230.0%Feb 26 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (5517)10/28/2012 11:06:45 PM
From: Gary Mohilner   of 5665
 
Frankly I'm still not certain we have the full story, but if it is, it's still a lot of money if T-DM1 is as successful as it should be.

IMGN's long term value has always been in it's pipeline. It's taking longer to develop than almost everyone I know thought it would, but it's still a very broad and deep pipeline and if IMGN remains independent, some day it should be one of the giant Biotech's.

Gary
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext